Jürgen Pünter - Veröffentlichungen allgemein

(1 - 9 von 10

)

Cellular and ionic mechanism for drug-induced long QT ...CORE

core.ac.uk

2005 · Zitiert von: 136 — Lang and Jürgen Pünter (Aventis. Pharma Deutschland GmbH, Frankfurt, Germany) for kindly providing the chromanol 293B Aiba et al. JACC Vol. 45, No. 2, ...

AVE0991, a Nonpeptide Compound, Attenuates Angiotensin II ...

downloads.hindawi.com

von C Sheng-Long · Zitiert von: 29 — kindly provided by Dr. Juergen Puenter of Aventis Pharma. (Frankfurt, Germany) and male Sprague-Dawley rats (10 to. › journals › ijhy

Ion transporters in brain endothelial cells that Springer Link

link.springer.com

von R Mokgokong · · Zitiert von: 52 — ... Josette Noel provided the n1p1 antibody; and Juergen Puenter (Sanofi-Aventis Deutschland GmbH) provided the cariporide. › article

Occludin S408 phosphorylation regulates tight junction ...Turner Lab

jrturnerlab.com

von DR Raleigh · · Zitiert von: 267 — for generously sharing advice; and Juergen Puenter and Roger Tsien for provid- ing essential reagents. This work was supported by the National Institutes of ...

Industrial IT services - MATERNA GmbH - Yumpu

www.yumpu.com

— Jürgen Pünter, Jan Schulze, Jochen Staub. Layout and design: VENNEKEL + PARTNER GmbH, MATERNA. Images: Federal Employment Agency (pages 4, ... › view › i...

Natriuretic peptides modulate ATP-sensitive K+ channels ...Springer

link.springer.com

von DS Burley · · Zitiert von: 23 — HMR1098, a selective sKATP inhibitor, was the kind gift of Dr Jürgen Pünter, Sanofi-Aventis Germany. With the exception of HMR1098, ...